Mini Review
Published on 22 Oct 2024
The evolving role of checkpoint inhibitors in the treatment of Hodgkin lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1392653
- 503 views
Type at least 3 characters
1,748 articles
Articles
Original Research
Accepted on 21 Oct 2024
Bone marrow involvement in solid tumors -a retrospective observational study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1434709
Original Research
Published on 17 Oct 2024
Effectiveness of high efficiency particulate (HEPA) air condition combined with the antifungal prophylaxis on incidence, morbidity and mortality of invasive fungal infections in patients with acute myeloid leukemia: a retrospective single-center study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1429221
- 644 views
Editorial
Published on 17 Oct 2024
Editorial: Novelties in acute myeloid leukemia: from biology to clinical applications
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1499272
- 461 views
Original Research
Published on 17 Oct 2024
COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021)
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1446482
- 819 views
Methods
Published on 14 Oct 2024
AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1458449
- 815 views
Systematic Review
Published on 11 Oct 2024
Association of CTLA-4 polymorphisms with hematologic malignancy susceptibility: a meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1467740
- 383 views
Brief Research Report
Published on 09 Oct 2024
Survival outcomes of patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation in Germany: real-world evidence from an administrative database between 2010 and 2019
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1432310
- 721 views
Correction
Published on 09 Oct 2024
Corrigendum: Quantitative Dixon and intravoxel incoherent motion diffusion magnetic resonance imaging parameters in lumbar vertebrae for differentiating aplastic anemia and acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1472773
- 327 views
Correction
Accepted on 03 Oct 2024
Corrigendum: Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1504102
Original Research
Published on 02 Oct 2024
Experience with luspatercept therapy in patients with transfusion-dependent low-risk myelodysplastic syndromes in real-world clinical practice: exploring the positive effect of combination with erythropoietin alfa
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1398331
- 670 views
Original Research
Published on 01 Oct 2024
The impact of delayed versus early administration of granulocyte colony-stimulating factor following autologous hematopoietic stem cell transplantation on transplantation outcome
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1468948
- 463 views
Case Report
Accepted on 30 Sep 2024
Case Report: HSV Lymphadenitis in Immunocompromised Patient with CLL
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1401208
Case Report
Published on 26 Sep 2024
Platelet HLA gene bank digital matching technology for platelet transfusion refractory patients with malignant tumors: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1419485
- 364 views
Brief Research Report
Published on 24 Sep 2024
Acute myeloid leukemia cells adhere to bone marrow and acquire chemoresistance by downregulating UNC5B expression
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1394443
- 689 views
Original Research
Published on 23 Sep 2024
How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1466803
- 882 views